Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Breast J. 2020 Oct;26(10):2021-2025. doi: 10.1111/tbj.14044. Epub 2020 Sep 13.
It is a clinical dilemma when a finding reported as suspicious on a breast MRI is not visualized at the time of a scheduled MRI-guided breast biopsy. We retrospectively reviewed all canceled MRI-guided biopsies at our institution between 6/1/2009 and 9/20/2019 and found a cancellation rate of 6.9% (72/1051). In one case, a mastectomy was performed after the canceled biopsy revealing a focus of DCIS in the same quadrant as the original finding (malignancy rate 2.1%). Our results support the current practice of 6-month follow-up MRI recommendation after a canceled MRI-guided biopsy for lesion nonvisualization.
当乳腺 MRI 报告的疑似发现未能在预定的 MRI 引导下乳腺活检时,这是一个临床难题。我们回顾性地审查了我们机构在 2009 年 6 月 1 日至 2019 年 9 月 20 日期间所有取消的 MRI 引导活检,发现取消率为 6.9%(72/1051)。在一个病例中,取消活检后进行了乳房切除术,显示出与原始发现相同象限的局灶性 DCIS(恶性率为 2.1%)。我们的结果支持当前的做法,即在取消的 MRI 引导活检后进行 6 个月的随访 MRI 推荐,以观察病变是否可视化。